Reducing Hereditary Cancer Act
The summary
What this bill does
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Legislative timeline
From introduction
Jul 23, 2025
Introduced & referred to committee
Congressional support
Sponsors & Cosponsors
Member of Congress · D-FL
27 cosponsors
U.S. Representative - IA District 1 · R-IA
U.S. Representative - WA District 8 · D-WA
U.S. Representative - FL District 16 · R-FL
Member of Congress · D-TN
U.S. Representative - MI District 6 · D-MI
Member of Congress · D-NJ
U.S. Representative - CA District 12 · D-CA
U.S. Representative - IN District 7 · D-IN
U.S. Representative - DC · D-DC
U.S. Representative - OR-1 · D-OR
U.S. Representative - CA District 31 · D-CA
U.S. Representative - IA District 3 · R-IA
+ 15 more cosponsors
Roll-call vote
The vote, by member
The vote, by member
VERSION CHANGES
What changed,
and where.
Loading the bill text comparison.
Bill Metadata
| Congress | 119 |
| Bill Type | HR |
| Bill Number | 4752 |
| Origin Chamber | House |
| Current Status | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| Policy Area | Health |
| Primary Committee | Not assigned |
| Introduced | July 23, 2025 |
| Latest Action | July 23, 2025 |
| Cosponsors | 27 · House vote — · — views |